Imaging Biomarkers Market Comprehensive Analysis and Future Estimations 2023

Free Press Release DB | Press Release Date : Feb 13, 2018  Download

The global imaging biomarkers market followed by the European countries due to well established healthcare infrastructure in these regions.

An imaging biomarker is a biomarker that can be detected with the help of an imaging technology. Biomarkers are increasingly being applied as a diagnostic tool. These are an objective measure for the level of activities of genes, proteins and other molecular features. According to the National Institutes of Health’s National Cancer Institute, biomarker is a biological molecule found in tissue, blood or other body fluids, which mark the presence of a normal or an abnormal process, or of a condition or disease. 

Report Overview @

Therefore, biomarkers are more useful to detect and monitor responses of the body to a disease or condition. Since cancer is associated with alterations in the status and expression of multiple genes, technologies are under development that could provide important insights into the etiology of the cancer and be vital to detect, diagnose, and treat cancer. Biomarkers, help in early detection of cancer, resulting in increased survival rate among cancer patients.

The global imaging biomarkers market is segmented on the basis of imaging technologies, applications and geography. Imaging technologies include positron emission tomography (PET), ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and single-photon emission computed tomography (SPECT). Personalized medicines, drug discovery and development, molecular diagnostics, drug formulation, disease diagnosis and forensic applications are the major application segments for imaging biomarkers. Determination of disease mechanisms, toxicity profiling, and in target discovery and validation are some of the key drivers propelling the demand for imaging biomarkers.

MRI procedures use magnetic field and are thus safer than other imaging techniques such as CT and PET scan. Multi parametric MRI is emerging as an improved technique and best imaging modality for localizing and staging of various cancers. PET scanners due to their high cost, have their usage limited to large hospitals. These are useful in cancer staging and to determine the preseance of metastasis. It is estimated that approximately 95% of all PET procedures performed are related to cancers and is the normal standard of care in the diagnosis, staging and determining treatment of cancer patients.

Request a Brochure of the Report @ 

Technologically advanced imaging modalities such as PET/MR, provide new tools for biomarker imaging by combining morphological and molecular imaging. Present day CT equipment produce 3D images by capturing pictures in a helical (or spiral) way and the most recent equipment have the ability to take more images in a very short time. In certain cases, contrast medium dyes are used during imaging for clear visualization of tissues. Ultrasound imaging has gained popularity along with mammogram for detecting breast cancer, as it is non-invasive, cost effective, and is widely available.

Geographically, the global imaging biomarkers market can be categorized into four major regions namely North America, Europe, Asia Pacific and Rest of the World. North America comprising of the U.S. and Canada dominates the global imaging biomarkers market followed by the European countries due to well established healthcare infrastructure in these regions. Emerging economies in the Asia Pacific region are expected to be the fastest growing region in the near future due to rising awareness regarding the imaging biomarkers and continuous improvement in the healthcare infrastructure. 

Various organizations have been formed in order to assist in biomarkers discovery and their assessment in drug development and response to therapy. These organizations include The Biomarkers Consortium, International Cancer Biomarker Consortium and The Predictive Safety Testing Consortium. Abbott Laboratories, Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Becton, Dickinson and Company, Affymetrix Inc., Danaher Corporation, Qiagen NV, DiagnoCure, Inc., Gen-Probe Inc., F. Hoffmann La Roche Ltd., and Siemens Healthcare. 

Enquiry for discount on this report @

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement. 

US Office Contact 

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453



Contact Person & Company



Aman Harper



Contact Numbers

Telephone No.


Fax No.


Handphone No.



Website 1


Website 2




PR Tags


Imaging Biomarkers Market,


Contact The Author

Contact Aman Harper

More Press Release From Author

Proliferative Diabetic Retinopathy Market is Poised to Reach Roughly US$ 1,000 Million by 2026-End

Free Press Release DB :

Revenues from treatment of proliferative diabetic retinopathy around the world are poised to reach roughly US$ 1,000 Mn by 2026-end. --> Read This Press Release !

By : Aman, Harper ( May 14, 2018 )
Category : Healthcare Press Release | Country : United States Press Release

Urinary Incontinence Treatment Devices Market to Expand at a CAGR of Over 7.0% from 2017 to 2025

Free Press Release DB :

The global urinary incontinence treatment devices market is driven by high prevalence and rapid increase in incidence of urinary incontinence across the globe. --> Read This Press Release !

By : Aman, Harper ( May 14, 2018 )
Category : Healthcare Press Release | Country : United States Press Release

Ophthalmology Surgical Devices Market is Projected to Register a CAGR of 4.0% from 2017 to 2025

Free Press Release DB :

Ophthalmology surgical devices market was valued at around US$ 7.0 Bn in 2016 and is expected to expand at a CAGR of over 4.0% from 2017 to 2025, to reach value of around US$ 11.0 Bn by 2025. --> Read This Press Release !

By : Aman, Harper ( May 14, 2018 )
Category : Healthcare Press Release | Country : United States Press Release

Read More Articles From Aman Harper


The author of the press releases are solely responsible for the content of their press releases. can't be held liable for the content posted by author. Please check the accuracy of the press release before using the press release. If necessary please contact the author. Thank you.

Report Abuse